Arming the oncolytic virus enadenotucirev (EnAd) to generate enhanced locally-acting immunotherapies for cancer

Benzer Materyaller

• "Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
  Yazar:: Champion, Brian R, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes
  Yazar:: Marino, Nalini, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
  Yazar:: Illingworth, Sam, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
  Yazar:: Dyer, Arthur, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
  Yazar:: Tedcastle, Alison, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)